Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(3.10)
# 1,343
Out of 5,044 analysts
821
Total ratings
42.39%
Success rate
1.57%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KURA Kura Oncology | Reiterates: Buy | $40 | $10.51 | +280.59% | 28 | Oct 20, 2025 | |
| NAMS NewAmsterdam Pharma Company | Assumes: Buy | $52 | $36.14 | +43.88% | 1 | Oct 20, 2025 | |
| ATXS Astria Therapeutics | Downgrades: Neutral | n/a | $12.47 | - | 23 | Oct 16, 2025 | |
| RIGL Rigel Pharmaceuticals | Reiterates: Buy | $57 | $29.69 | +91.98% | 27 | Oct 8, 2025 | |
| CYTK Cytokinetics | Reiterates: Buy | $120 | $61.97 | +93.64% | 50 | Sep 29, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $102 | $34.93 | +192.01% | 35 | Sep 29, 2025 | |
| GUTS Fractyl Health | Maintains: Buy | $9 → $8 | $1.28 | +525.00% | 2 | Sep 26, 2025 | |
| CAPR Capricor Therapeutics | Reiterates: Buy | $24 | $6.18 | +288.35% | 26 | Sep 25, 2025 | |
| BCDA BioCardia | Reiterates: Buy | $25 | $1.37 | +1,724.82% | 17 | Sep 22, 2025 | |
| ESPR Esperion Therapeutics | Reiterates: Buy | $16 | $3.04 | +426.32% | 30 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $47 | $29.81 | +57.67% | 5 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.96 | - | 10 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $189.65 | +26.55% | 34 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.37 | +191.97% | 23 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.56 | +220.51% | 18 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $4.71 | +345.86% | 2 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.78 | +439.57% | 17 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $17 | $2.56 | +564.06% | 4 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $42 | $27.07 | +55.15% | 36 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.58 | +2,496.95% | 16 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.19 | +813.24% | 29 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $30 | $9.61 | +212.11% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $10 | $6.43 | +55.52% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.35 | - | 23 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $0.93 | +1,293.35% | 32 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $16.42 | +155.79% | 1 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $2.16 | +548.15% | 2 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $53 | $105.14 | -49.59% | 2 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.48 | +170.27% | 31 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.73 | +420.23% | 12 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.48 | +728.33% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $5.14 | +16.73% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $3.77 | +589.66% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.94 | +415.46% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.51 | - | 4 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $104 | $34.57 | +200.84% | 24 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $4.99 | +80.36% | 15 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $1.50 | +1,033.33% | 1 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $12.88 | +148.45% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.11 | +414.47% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $250 | $10.83 | +2,209.47% | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.66 | +1,257.47% | 1 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $1.38 | +1,204.35% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $4.10 | +485.37% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 | $10.89 | +46.92% | 19 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.58 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $9.37 | +230.84% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.14 | +952.63% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.01 | - | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $37 | $13.76 | +168.90% | 17 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.55 | +609.68% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.42 | +1,308.45% | 14 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $2.40 | +941.67% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.50 | +6,566.67% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.85 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $30 | $1.93 | +1,454.40% | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.56 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $34.55 | -4.49% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $8.85 | +781.36% | 1 | Mar 24, 2017 |
Kura Oncology
Oct 20, 2025
Reiterates: Buy
Price Target: $40
Current: $10.51
Upside: +280.59%
NewAmsterdam Pharma Company
Oct 20, 2025
Assumes: Buy
Price Target: $52
Current: $36.14
Upside: +43.88%
Astria Therapeutics
Oct 16, 2025
Downgrades: Neutral
Price Target: n/a
Current: $12.47
Upside: -
Rigel Pharmaceuticals
Oct 8, 2025
Reiterates: Buy
Price Target: $57
Current: $29.69
Upside: +91.98%
Cytokinetics
Sep 29, 2025
Reiterates: Buy
Price Target: $120
Current: $61.97
Upside: +93.64%
Viking Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $102
Current: $34.93
Upside: +192.01%
Fractyl Health
Sep 26, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.28
Upside: +525.00%
Capricor Therapeutics
Sep 25, 2025
Reiterates: Buy
Price Target: $24
Current: $6.18
Upside: +288.35%
BioCardia
Sep 22, 2025
Reiterates: Buy
Price Target: $25
Current: $1.37
Upside: +1,724.82%
Esperion Therapeutics
Sep 19, 2025
Reiterates: Buy
Price Target: $16
Current: $3.04
Upside: +426.32%
Sep 19, 2025
Reiterates: Buy
Price Target: $47
Current: $29.81
Upside: +57.67%
Sep 15, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.96
Upside: -
Sep 15, 2025
Reiterates: Buy
Price Target: $240
Current: $189.65
Upside: +26.55%
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.37
Upside: +191.97%
Sep 2, 2025
Reiterates: Buy
Price Target: $5
Current: $1.56
Upside: +220.51%
Aug 26, 2025
Reiterates: Buy
Price Target: $21
Current: $4.71
Upside: +345.86%
Aug 21, 2025
Reiterates: Buy
Price Target: $15
Current: $2.78
Upside: +439.57%
Aug 21, 2025
Maintains: Buy
Price Target: $26 → $17
Current: $2.56
Upside: +564.06%
Aug 20, 2025
Maintains: Buy
Price Target: $50 → $42
Current: $27.07
Upside: +55.15%
Aug 20, 2025
Reiterates: Buy
Price Target: $15
Current: $0.58
Upside: +2,496.95%
Aug 19, 2025
Reiterates: Buy
Price Target: $20
Current: $2.19
Upside: +813.24%
Aug 5, 2025
Maintains: Buy
Price Target: $5 → $30
Current: $9.61
Upside: +212.11%
Aug 4, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $6.43
Upside: +55.52%
Jul 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.35
Upside: -
Jul 1, 2025
Reiterates: Buy
Price Target: $13
Current: $0.93
Upside: +1,293.35%
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $16.42
Upside: +155.79%
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $2.16
Upside: +548.15%
Jun 24, 2025
Maintains: Buy
Price Target: $41 → $53
Current: $105.14
Upside: -49.59%
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.48
Upside: +170.27%
Jun 23, 2025
Reiterates: Buy
Price Target: $9
Current: $1.73
Upside: +420.23%
Jun 18, 2025
Reiterates: Buy
Price Target: $4
Current: $0.48
Upside: +728.33%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $5.14
Upside: +16.73%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $3.77
Upside: +589.66%
Jun 11, 2025
Reiterates: Buy
Price Target: $10
Current: $1.94
Upside: +415.46%
Jun 2, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.51
Upside: -
May 28, 2025
Reiterates: Buy
Price Target: $104
Current: $34.57
Upside: +200.84%
May 19, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $4.99
Upside: +80.36%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $1.50
Upside: +1,033.33%
May 16, 2025
Reiterates: Buy
Price Target: $32
Current: $12.88
Upside: +148.45%
May 15, 2025
Reiterates: Buy
Price Target: $16
Current: $3.11
Upside: +414.47%
May 13, 2025
Reiterates: Buy
Price Target: $250
Current: $10.83
Upside: +2,209.47%
May 8, 2025
Assumes: Buy
Price Target: $9
Current: $0.66
Upside: +1,257.47%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.38
Upside: +1,204.35%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $4.10
Upside: +485.37%
Apr 10, 2025
Downgrades: Neutral
Price Target: $16
Current: $10.89
Upside: +46.92%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.58
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $9.37
Upside: +230.84%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $1.14
Upside: +952.63%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.01
Upside: -
Mar 21, 2025
Reiterates: Buy
Price Target: $37
Current: $13.76
Upside: +168.90%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.55
Upside: +609.68%
Jan 15, 2025
Reiterates: Buy
Price Target: $20
Current: $1.42
Upside: +1,308.45%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $2.40
Upside: +941.67%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $1.50
Upside: +6,566.67%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.85
Upside: -
Nov 3, 2020
Upgrades: Buy
Price Target: $30
Current: $1.93
Upside: +1,454.40%
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.56
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $34.55
Upside: -4.49%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $8.85
Upside: +781.36%